Congenital Hypogonadotropic Hypogonadism

Abstract

  1. 1.

    Review the variable clinical presentation of men with CHH

     
  2. 2.

    Summarize what is known about the gene defects causing CHH

     
  3. 3.

    Understand treatment options for gonadotropin-deficient men

     

Keywords

Congenital hypogonadotropic hypogonadism CHH Gonadotropin-deficient Hypogonadal Gynecomastia 

References

  1. 1.
    Balasubramanian R, Crowley Jr WF. Isolated GnRH deficiency: a disease model serving as a unique prism into the systems biology of the GnRH neuronal network. Mol Cell Endocrinol. 2011;346(1–2):4–12.PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Chevrier L, Guimiot F, de Roux N. GnRH receptor mutations in isolated gonadotropic deficiency. Mol Cell Endocrinol. 2011;346(1–2):21–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Miraoui H, Dwyer AA, Sykiotis GP, Plummer L, Chung W, Feng B, Beenken A, Clarke J, Pers TH, Dworzynski P, Keefe K, Niedziela M, Raivio T, Crowley Jr WF, Seminara SB, Quinton R, Hughes VA, Kumanov P, Young J, Yialamas MA, Hall JE, Van Vliet G, Chanoine JP, Rubenstein J, Mohammadi M, Tsai PS, Sidis Y, Lage K, Pitteloud N. Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet. 2013;92:725–43.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Laitinen EM, Tommiska J, Sane T, Vaaralahti K, Toppari J, Raivio T. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations. PLoS One. 2012;7:e39450.PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Burris AS, Rodbard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab. 1988;66(6):1144–51.CrossRefPubMedGoogle Scholar
  6. 6.
    Matsumoto AM, Snyder PJ, Bhasin S, Martin K, Weber T, Winters S, Spratt D, Brentzel J, O’Dea L. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertil Steril. 2009;92:979–90.CrossRefPubMedGoogle Scholar
  7. 7.
    Laitinen EM, Hero M, Vaaralahti K, Tommiska J, Raivio T. Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism. Int J Androl. 2012;35:534–40.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Division of Endocrinology, Metabolism and DiabetesUniversity of LouisvilleLouisvilleUSA

Personalised recommendations